Skip to main content

The ultimate test. The need to get new drugs to market faster is critical; so too is the need to control costs and protect public safety.

Our view: Bringing a pharmaceutical or biologic product to market takes more than just good science. It takes an agile business to respond to the changing market dynamics.

Read the IBM Institute for Business Value report: The new biopharmaceutical blueprint: Aligning business and IT with service-oriented architecture (US)

What we offer

Business solutions

Deep industry expertise provides the foundation for solving the most complex business problems.

Real results

Bayer helps develop the cures of the future with electronic capture of clinical trial data.

  • Paul Papas

    “Life sciences companies are innovation based at their core and the rapidly changing healthcare ecosystem requires them to not only bring new and innovative treatments to market, but to rethink their internal and external business models.”

    Paul Papas
    Americas Life Sciences Leader, IBM Global Business Services

Related offerings

We're here to help

We're here to help

Easy ways to get the answers you need.


or call us at 1800 557 343.

IBM 2008 Global Human Capital Study

IBM 2008 Global Human Capital Study

What are the critical factors that lead to effective workforce transformation?